This content is from:xinyabo体育

A New Biotech Fund for Suvretta

Averill will be completely separate from Suvretta’s existing funds but share the firm’s infrastructure.

New York City, New York. (Michael Nagle/Bloomberg)
New York City, New York. (Michael Nagle/Bloomberg)

Suvretta Capital Management is raising money for a new fund that will launch on April 1.The fund, called Averill, will be completely separate from Suvretta’s existing funds but will use the firm’s infrastructure, according to a Suvretta investor.Averill will be a long-short fund specializing in biotech stocks and led by

To continue reading,subscribe nowto Premium Journalism. Already a subscriber?Login.

Related Content